Latin American Consensus on management of residual cardiometabolic risk. A consensus paper prepared by the Latin American Academy for the Study of Lipids and Cardiometabolic Risk (ALALIP) endorsed by the Inter-American Society of Cardiology (IASC), the International Atherosclerosis Society (IAS), and the Pan-American College of Endothelium (PACE)

Background: Hypertension, hyperglycemia, dyslipidemia, overweight, obesity, and tobacco (smoking, chewing, and vaping), together with a pro-inflammatory and procoagulant state, are the main risk factors related to atherosclerotic cardiovascular disease. Objective and methods: A group of experts from...

Full description

Bibliographic Details
Main Authors:	Amaro, A.J.J (Author), Badimon, J.J (Author), Berrospi, P. (Author), Bryce, A. (Author), Cobos S., L. (Author), Duran, M. (Author), Gomez-Mancebo, J.R (Author), González, J.J.R (Author), Lanas, F. (Author), Lara, J. (Author), Libby, P. (Author), López-Jaramillo, P. (Author), Lorenzatti, A. (Author), Lozada, A.F (Author), Medina-Palomino, F.A (Author), Miranda, D. (Author), Piskorz, D. (Author), Ponte-Negretti, C.I (Author), Puente-Barragan, A. (Author), Rodrigo, A.K (Author), Santos, R.D (Author), Toth, P.P (Author), Ullauri-Solórzano, V.E (Author), Urina-Triana, M. (Author), Valdés, T.O (Author), Villar, R. (Author), Wyss, F.S (Author)
Format:	Article
Language:	English
Published:	Instituto Nacional de Cardiologia Ignazio Chavez 2022
Subjects:	abdominal obesity acetylsalicylic acid anticoagulant agent antilipemic agent anxiety aortic stenosis apolipoprotein B Article atherosclerosis Atherosclerosis Atherosclerotic cardiovascular disease body weight loss brain hemorrhage canagliflozin cardiology Cardiology cardiometabolic risk cardiometabolic risk factor Cardiometabolic risk factors cardiovascular risk Cardiovascular risk chemical structure cholesterol clopidogrel cognitive defect colchicine consensus Consensus coronary artery atherosclerosis coronary artery disease cost benefit analysis cost effectiveness analysis dapagliflozin Delphi study dual antiplatelet therapy dulaglutide dyslipidemia empagliflozin endothelium Endothelium evolocumab exendin 4 exercise ezetimibe ezetimibe plus simvastatin fenofibrate gemfibrozil glucagon like peptide 1 glucose blood level glucose metabolism glycemic control health care cost heart muscle revascularization hematocrit hemoglobin A1c high density lipoprotein cholesterol human Humans hydroxymethylglutaryl coenzyme A reductase inhibitor hypercholesterolemia hyperglycemia inflammation Inflammation insulin treatment Inter American Society of Cardiology International Atherosclerosis Society Latin America lifestyle modification lipid Lipids low density lipoprotein maximum tolerated dose medical society medication compliance metformin monotherapy mortality nutrition obesity omega 3 fatty acid Pan American College of Endothelium personalized medicine practice guideline prasugrel prescription proprotein convertase 9 public health public health problem Residual risk risk factor risk reduction rivaroxaban secondary prevention semaglutide social determinants of health sodium glucose cotransporter 2 inhibitor South and Central America Thrombosis triacylglycerol United States
Online Access:	View Fulltext in Publisher

Internet

View Fulltext in Publisher

Internet

Similar Items